Diabetic neuropathy and oxidative stress

Diabetes/metabolism Research and Reviews
Rodica Pop-BusuiMartin Stevens

Abstract

This review will focus on the impact of hyperglycemia-induced oxidative stress in the development of diabetes-related neural dysfunction. Oxidative stress occurs when the balance between the production of reactive oxygen species (ROS) and the ability of cells or tissues to detoxify the free radicals produced during metabolic activity is tilted in the favor of the former. Although hyperglycemia plays a key role in inducing oxidative stress in the diabetic nerve, the contribution of other factors, such as endoneurial hypoxia, transition metal imbalances, and hyperlipidemia have been also suggested. The possible sources for the overproduction of ROS in diabetes are widespread and include enzymatic pathways, auto-oxidation of glucose, and mitochondrial superoxide production. Increase in oxidative stress has clearly been shown to contribute to the pathology of neural and vascular dysfunction in diabetes. Potential therapies for preventing increased oxidative stress in diabetic nerve dysfunction will be discussed.

References

Sep 1, 1975·Brain : a Journal of Neurology·P A LowJ G McLeod
Jul 24, 1978·Life Sciences·H E HarrisonM Johnson
Dec 1, 1992·Diabetes Care·D A GreeneS A Lattimer
Jan 1, 1992·Advances in Experimental Medicine and Biology·J B Lombardini
Jul 1, 1992·The American Journal of Physiology·O GoureauS Harbon
Jun 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·T J Lyons
Oct 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·E VelázquezM F Laker
Jan 1, 1991·Free Radical Biology & Medicine·S P WolffJ V Hunt
Mar 1, 1991·Diabetes/metabolism Reviews·G PuglieseJ R Williamson
Jan 1, 1990·Methods in Enzymology·R L LevineE R Stadtman
Mar 1, 1990·Pediatric Research·J I MaloneW R Cook
Dec 31, 1990·Biochemical and Biophysical Research Communications·C J MullarkeyM Brownlee
Jan 1, 1990·Advances in Experimental Medicine and Biology·A Bendich
Jan 1, 1990·Advances in Experimental Medicine and Biology·B FreiB N Ames
Mar 1, 1990·The Journal of Clinical Investigation·B TesfamariamR A Cohen
Aug 29, 1988·FEBS Letters·T Sakurai, S Tsuchiya
Sep 1, 1987·Diabetic Medicine : a Journal of the British Diabetic Association·P E JenningsA H Barnett
Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S M BagnascoM B Burg
Jun 1, 1988·The American Journal of Physiology·S M BagnascoM B Burg
Mar 1, 1988·The Journal of Clinical Investigation·M B Burg, P F Kador
Apr 1, 1988·Mayo Clinic Proceedings·P A Southorn, G Powis
Jan 1, 1987·Advances in Experimental Medicine and Biology·R J Huxtable
Jan 1, 1986·Annual Review of Biochemistry·C E WrightG E Gaull
Jul 1, 1983·Metabolism: Clinical and Experimental·D A Greene
May 1, 1983·Diabetes Care·T Gundersen, J Kjekshus
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H VlassaraA Cerami
Jun 1, 1981·Biochemical Medicine·I NishigakiK Yagi
Jan 1, 1995·Advances in Pharmacology·K K Wu
Sep 28, 1995·Biochemical Pharmacology·S VerhaegenT G Cotter

❮ Previous
Next ❯

Citations

Jan 18, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Neha ChauhanPyare Lal Sharma
Aug 13, 2011·Accounts of Chemical Research·Alexander R LippertChristopher J Chang
Mar 6, 2010·Journal of the American Chemical Society·Duangkhae SrikunChristopher J Chang
Mar 4, 2011·Journal of the American Chemical Society·Alexander R LippertChristopher J Chang
Mar 25, 2011·Journal of Agricultural and Food Chemistry·Yung-Chang LuGeorge Hsiao
Jun 15, 2007·Nature Clinical Practice. Neurology·Rodica Pop-Busui
Aug 3, 2007·Nature Clinical Practice. Neurology·Klaus-Armin NaveHannelore Ehrenreich
May 1, 2009·Nature Reviews. Drug Discovery·Nigel A CalcuttAnn Marie Schmidt
Jan 1, 2009·Nature Reviews. Drug Discovery·Ardem PatapoutianClifford J Woolf
Sep 15, 2010·Chemical Communications : Chem Comm·Alexander R LippertChristopher J Chang
Dec 26, 2012·Proceedings of the National Academy of Sciences of the United States of America·Tie-Jun Sten ShiTomas G M Hökfelt
Mar 26, 2011·Diabetes, Obesity & Metabolism·C MorgadoI Tavares
Jan 24, 2011·Journal of Diabetes Investigation·Soroku YagihashiKazuhiro Sugimoto
Aug 14, 2012·Pharmacological Reviews·Kevin L FarmerRick T Dobrowsky
Apr 26, 2008·Experimental Diabetes Research·Anders A F SimaHideki Kamiya
May 2, 2012·The Journal of Clinical Investigation·Kai Soo TanYunn-Hwen Gan
Jul 29, 2011·Reproductive Biology and Endocrinology : RB&E·Glaura S A FernandesWilma D G Kempinas
Apr 9, 2008·Journal of Leukocyte Biology·Kazuhiro OmoriThomas E Van Dyke
Jan 28, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira MatsukiHiroshi Inoue
Mar 30, 2011·Drugs·Howard S Smith, Charles E Argoff
Mar 10, 2009·Pakistan Journal of Biological Sciences : PJBS·H R SameniM Makvandi
Mar 26, 2010·International Journal of Diabetes in Developing Countries·Namita G Hattangady, Medha S Rajadhyaksha
Aug 17, 2010·ASN Neuro·Michael J UrbanRick T Dobrowsky
Jun 14, 2014·Journal of Diabetes and Metabolic Disorders·Niral PatelRam K Dikshit
Dec 25, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Di LiuMengren Zhang
Jul 29, 2009·Journal of Endocrinological Investigation·H WangH Duan
Oct 18, 2011·Pharmacological Reports : PR·Glaura S A FernandesWilma D G Kempinas
Oct 14, 2014·Journal of the American Chemical Society·Valerie CarrollChristopher J Chang
Feb 2, 2011·The Medical Clinics of North America·Sofiya Milman, Jill P Crandall
Apr 27, 2010·The Journal of Pain : Official Journal of the American Pain Society·Kanwaljit ChopraAnurag Kuhad
Sep 8, 2009·Trends in Endocrinology and Metabolism : TEM·Robert O PoytonPablo R Castello
Apr 28, 2009·European Journal of Pharmacology·Corinne G JolivaltNigel A Calcutt
Nov 26, 2008·Journal of Proteomics·Yannick BrunnerJean-Charles Sanchez
Sep 3, 2008·Journal of Ethnopharmacology·A MuthuramanDhandeep Singh
Jul 3, 2008·European Journal of Pharmacology·Guillermina Yanek Jiménez-AndradeVinicio Granados-Soto
Apr 15, 2008·Experimental Neurology·Muragundla AnjaneyuluJames W Russell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.